Download PDF

Other users also viewed these articles

Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease Chenyang Mu; Sijie Wang; Zenghan Wang; Jian Tan; Haozan Yin; Yuefan Wang; Zhihui Dai; Dongyang Ding; Fu Yang;
10.1016/j.aohep.2024.101774
The role of inflammasomes in hepatocellular carcinoma: Mechanisms and therapeutic insights Valentina Arrè; Roberto Negro; Gianluigi Giannelli;
10.1016/j.aohep.2024.101772
Metabolic dysfunction: The silenced connection with fatty liver disease Mariana M. Ramírez-Mejía; Xingshun Qi; Ludovico Abenavoli; Manuel Romero-Gómez; Mohammed Eslam; Nahum Méndez-Sánchez;
Ann Hepatol. 2023;28: